Molecular characterization of ESBL-producing Klebsiella pneumoniae isolates from intensive care patients;Molekulárno-biologická analýze ESBL-pozitívnych izolátov Klebsiella pneumoniae od pacientov v intenzívnej starostlivosti

Klinicka Mikrobiologie a Infekcni Lekarstvi

Volumn 13, Issue 5, 2007, Pages 206-211

  Chromá, Magdaléna ^a   Kolar M ^a   Sauer, P ^a   Marek, O ^b   Koukalova D ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

Author keywords

ESBL; Genetic analysis; Klebsiella pneumoniae

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE SHV; CEFOPERAZONE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DNA FRAGMENT; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; MEROPENEM; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; PROTEIN TEM; PROTEIN XBA1; RESTRICTION ENDONUCLEASE; SODIUM PROTON EXCHANGE PROTEIN 1; SULPERAZON; SULTAMICILLIN; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DILUTION; DNA DETERMINATION; ENZYME ANALYSIS; ENZYME DEGRADATION; ENZYME SYNTHESIS; GENE MUTATION; HOSPITAL DEPARTMENT; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MUTATIONAL ANALYSIS; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UNIVERSITY HOSPITAL;

EID: 37849018291     PISSN: 1211264X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Livermore DM, Paterson DL. Pocket guide to extended spectrum β-lactamases in resistance. Spain: Current Medicine Group Ltd; 2006.
2. Bradford PA. Extended-spectrum-β-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14:933-951.
3. Ambler RP. The structure of β-lactamases. Phil Trans R Soc Lond Biol Sc. 1980;289:321-331.
4. Bush K, Jacoby G, Medeiros A. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995;39:1211-1233.
5. Kliebe C, Nies BA, Meyer JF, et al. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother. 1985;28:302-307.
6. Knothe H, Shah P, Kremery V, et al. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates Klebsiella pneumoniae and Serratia marcescens. Infection. 1983;11:315-317.
7. Bauernfeind A, Casellas JM, Goldberg M, et al. A new plasmidic cefotaxime from patients infected with Salmonella typhimurium. Infection. 1992;20:158-163.
8. Bauernfeind A, Stemplinger I, Jungwirth R, et al. Sequences of β-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other β-lactamases. Antimicrob Agents Chemother. 1996;40:509-513.
9. Kolář M, Urbánek K, Látal T. Antibiotic selection pressure and development of bacterial resistance. Intern J Antimicrob Agents. 2001;17:357-363.
10. Urbánek K, Kolář M, Lovečkoyá Y, et al. Influence of 3rd generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains. J Clin Pharm Therap. 2007;32:403-408.
11. Arlet G, Brami G, Décr D, et al. Molecular characterisation by PCR-restriction fragment length polymorphism of TEM β-lactamases. FEMS Microbiology Letters. 1995;134:203-208.
12. Chanawong A, M'Zali F, Heritage J, et al. Characterisation of extended-spectrum β-lactamases of the SHV family using a combination of PCR-single strand conformational polymorphism (PCR-SSCP) and PCR-restriction fragment length polymorphism (PCR-RFLP). FEMS Microbiology Letters. 2000;184:85-89.
13. Mabilat C, Goussard S. PCR detection and identification of genes for extended spectrum β-lactamases. In: Persing DH, Smith TF, Ternover TC and White TJ (eds). Diagnostic Molecular Microbiology. American Society for Microbiology. Washington DC; 1993.553-559.
14. M'Zali FH, Gascoyne-Binzi DM, Heritage J, Hawkea PM. Detection of mutations conferring extended-spectrum activity on SHV β-lactamases using polymerase chain reaction single strand conformational polymorphism (PCR-SSCP). J Antimicrob Chemother. 1996;37: 797-802.
15. Nüesch-Inderbinen NT, Hachler H, Kayser FH. Detection of genes coding for extended spectrum SHV β-lactamases in clinical isolates by molecular genetic method, and comparison with the Etest. Eur J Clin Microbiol Infect Dis. 1996; 15:398-402.
16. Bert F, Branger C, Lambert-Zechovsky N. Identification of PSE and OXA β-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. J Antimicrob Chemother. 2005;50:11-18.
17. Gori A, Espinasse F, Deplano A Comparison of pulsed-field gel electrophoresis and randomly amplified DNA polymorphism analysis for typing extended-spectrum β-lactamase producing Klebsiella pneumoniae. J Clin Microbiol. 1996;34: 2448-2453.
18. Moscovitz H, Shofer F, Mignott H, et al. Plasma cytokine determination in emergency department pacients as a predictor of bacteriemia and infectious disease severity. Crit Care Med. 1994;22:1102-1107.
19. Performance standards for antimicrobial susceptibility testing, seventeenth informational supplement. M100-S17. CLSI;2007.
20. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988;10:867-878.
21. Tzelepi E, Giakkoupi P, Sofianou D, et al. Detection of extended-spectrum β-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol. 2000;38:542-546.
22. Kolář M. Klinický význam girokospektrých β-laktamáz a zkušenosti s jejich identifikací v mikrobiologické praxi. Klin Alikrobiol Inf Lék. 2007; v tisku.
23. Cao V, Lambert T, Nhu DQ, et al. Distribution of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae in Vietnam. Antimicrob Agents Chemother. 2002;46(12):3739-3743.
24. Girlich D, Karim A, Poirel L, et al. Molecular epidemiology of an outbreak due IRT-2 beta-lactamase-producing strains of Klebsiella pneumoniae in a geriatric department. J Antimicrob Chemother. 2000;45:467-473.
25. Shi ZY, Liu PYF, Lau YJ, et al. Epidemiological typing of isolates from an outbreak of infection with multidrug-resistant Enterobacter cloacae by repetitive extragenic palindromic unit b1-primed PCR and pulsed-field gel electrophoresis. J Clin Microbiol. 1996;34:2784-2790.
26. Babini GS, Livermore DM. Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998. J Antimicrob Chemother. 2000; 45:183-189.
27. Hanberger H, Garcia-Rodriguez JA, Gobernado M, et al. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA 1999;281:67-71.
28. Kolář M, Látal T, Čermák P. et al. Prevalence ESBL-pozitivních Klebsiella pneumoniae v České republice a jejich molekulárně-biologická analýza. Klin Mikrobiol Inf Lék. 2005;11:92-99.
29. Pena C, Pujol M, Ardanuy C, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1998;42:53-58.
30. Paterson DL, Hujer KM, Hujer AM, et al. Extended spectrum β-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: Dominance and widespread prevalence of SHV- and CTX-M-type β-lactamases. Antimicrob Agents Chemother. 2003; 47:3354-3560.
31. Steward CD, Rasheed JK, Hubert SK, et al. Characterization of clinical isolates of Kiebsiella pneumoniae from 19 laboratories using the National Comittee for Clinical Laboratory Standards extended-spectrum β-lactamase detection methods. J Clin Microbiol. 2001;39:2864-2872.